APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sacubitril Valsartan Sodium Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sacubitril Valsartan Sodium Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025193 pages

Choose your research edition.

Industry ResearchSacubitril Valsartan Sodium Drugs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Sacubitril Valsartan Sodium Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Sacubitril Valsartan Sodium Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sacubitril Valsartan Sodium Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Sacubitril Valsartan Sodium Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Sacubitril Valsartan Sodium Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sacubitril Valsartan Sodium Drugs include Addii Biotech, Arlak Corazon, Cipla, Farmanova pharma, General Pharmaceuticals, MSN, Novartis, Sanof and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sacubitril Valsartan Sodium Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sacubitril Valsartan Sodium Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sacubitril Valsartan Sodium Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sacubitril Valsartan Sodium Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sacubitril Valsartan Sodium Drugs Segment by Company

Addii Biotech

Arlak Corazon

Cipla

Farmanova pharma

General Pharmaceuticals

MSN

Novartis

Sanof

Changzhou Pharmaceutical Factory

Chengdu Brilliant Pharmaceutical

TC Pharmaceuticals (Jiangsu)

Sino Therapeutics

Kelun Pharmaceutical

Qilu Pharmaceutical

Shenzhen Salubris Pharmaceuticals

CSPC Ouyi Pharmaceutical

Sihuan Pharmaceutical

Zhejiang AngLiKang Pharmaceutical

Zhejiang Nord Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Sacubitril Valsartan Sodium Drugs Segment by Type

Tablets

Oral Pellets

Sacubitril Valsartan Sodium Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Sacubitril Valsartan Sodium Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacubitril Valsartan Sodium Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sacubitril Valsartan Sodium Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacubitril Valsartan Sodium Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sacubitril Valsartan Sodium Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sacubitril Valsartan Sodium Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sacubitril Valsartan Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sacubitril Valsartan Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sacubitril Valsartan Sodium Drugs Industry Trends Table 2. Sacubitril Valsartan Sodium Drugs Industry Drivers Table 3. Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges Table 4. Sacubitril Valsartan Sodium Drugs Industry Restraints Table 5. Global Sacubitril Valsartan Sodium Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sacubitril Valsartan Sodium Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Manufacturers Table 9. Global Sacubitril Valsartan Sodium Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sacubitril Valsartan Sodium Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sacubitril Valsartan Sodium Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sacubitril Valsartan Sodium Drugs Manufacturers, Product Type & Application Table 13. Global Sacubitril Valsartan Sodium Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sacubitril Valsartan Sodium Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Oral Pellets Table 18. Global Sacubitril Valsartan Sodium Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Type (2021-2026) Table 22. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Type (2027-2032) Table 23. Global Sacubitril Valsartan Sodium Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Other Table 31. Global Sacubitril Valsartan Sodium Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2026) & (K Units) Table 33. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2027-2032) & (K Units) Table 34. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Application (2021-2026) Table 35. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Application (2027-2032) Table 36. Global Sacubitril Valsartan Sodium Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2021-2026) & (K Units) Table 38. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2027-2032) & (K Units) Table 39. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Sacubitril Valsartan Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Region (2021-2026) Table 44. Global Sacubitril Valsartan Sodium Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Sacubitril Valsartan Sodium Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 48. North America Sacubitril Valsartan Sodium Drugs Sales by Country (2027-2032) & (K Units) Table 49. Europe Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 51. Europe Sacubitril Valsartan Sodium Drugs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Sacubitril Valsartan Sodium Drugs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Region (2027-2032) Table 63. Addii Biotech Company Information Table 64. Addii Biotech Business Overview Table 65. Addii Biotech Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio Table 67. Addii Biotech Recent Development Table 68. Arlak Corazon Company Information Table 69. Arlak Corazon Business Overview Table 70. Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio Table 72. Arlak Corazon Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio Table 77. Cipla Recent Development Table 78. Farmanova pharma Company Information Table 79. Farmanova pharma Business Overview Table 80. Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio Table 82. Farmanova pharma Recent Development Table 83. General Pharmaceuticals Company Information Table 84. General Pharmaceuticals Business Overview Table 85. General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio Table 87. General Pharmaceuticals Recent Development Table 88. MSN Company Information Table 89. MSN Business Overview Table 90. MSN Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. MSN Sacubitril Valsartan Sodium Drugs Product Portfolio Table 92. MSN Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio Table 97. Novartis Recent Development Table 98. Sanof Company Information Table 99. Sanof Business Overview Table 100. Sanof Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio Table 102. Sanof Recent Development Table 103. Changzhou Pharmaceutical Factory Company Information Table 104. Changzhou Pharmaceutical Factory Business Overview Table 105. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio Table 107. Changzhou Pharmaceutical Factory Recent Development Table 108. Chengdu Brilliant Pharmaceutical Company Information Table 109. Chengdu Brilliant Pharmaceutical Business Overview Table 110. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 112. Chengdu Brilliant Pharmaceutical Recent Development Table 113. TC Pharmaceuticals (Jiangsu) Company Information Table 114. TC Pharmaceuticals (Jiangsu) Business Overview Table 115. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio Table 117. TC Pharmaceuticals (Jiangsu) Recent Development Table 118. Sino Therapeutics Company Information Table 119. Sino Therapeutics Business Overview Table 120. Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio Table 122. Sino Therapeutics Recent Development Table 123. Kelun Pharmaceutical Company Information Table 124. Kelun Pharmaceutical Business Overview Table 125. Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 127. Kelun Pharmaceutical Recent Development Table 128. Qilu Pharmaceutical Company Information Table 129. Qilu Pharmaceutical Business Overview Table 130. Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 132. Qilu Pharmaceutical Recent Development Table 133. Shenzhen Salubris Pharmaceuticals Company Information Table 134. Shenzhen Salubris Pharmaceuticals Business Overview Table 135. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio Table 137. Shenzhen Salubris Pharmaceuticals Recent Development Table 138. CSPC Ouyi Pharmaceutical Company Information Table 139. CSPC Ouyi Pharmaceutical Business Overview Table 140. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 142. CSPC Ouyi Pharmaceutical Recent Development Table 143. Sihuan Pharmaceutical Company Information Table 144. Sihuan Pharmaceutical Business Overview Table 145. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 147. Sihuan Pharmaceutical Recent Development Table 148. Zhejiang AngLiKang Pharmaceutical Company Information Table 149. Zhejiang AngLiKang Pharmaceutical Business Overview Table 150. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 152. Zhejiang AngLiKang Pharmaceutical Recent Development Table 153. Zhejiang Nord Pharmaceutical Company Information Table 154. Zhejiang Nord Pharmaceutical Business Overview Table 155. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 157. Zhejiang Nord Pharmaceutical Recent Development Table 158. Chia Tai Tianqing Pharmaceutical Company Information Table 159. Chia Tai Tianqing Pharmaceutical Business Overview Table 160. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 162. Chia Tai Tianqing Pharmaceutical Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Sacubitril Valsartan Sodium Drugs Distributors List Table 166. Sacubitril Valsartan Sodium Drugs Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Sacubitril Valsartan Sodium Drugs Product Image Figure 2. Global Sacubitril Valsartan Sodium Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sacubitril Valsartan Sodium Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Sacubitril Valsartan Sodium Drugs Sales (2021-2032) & (K Units) Figure 5. Global Sacubitril Valsartan Sodium Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sacubitril Valsartan Sodium Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Oral Pellets Image Figure 10. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Sacubitril Valsartan Sodium Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Retail Pharmacies Image Figure 18. Other Image Figure 19. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Sacubitril Valsartan Sodium Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2032) Figure 39. China Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Sacubitril Valsartan Sodium Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Sacubitril Valsartan Sodium Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Sacubitril Valsartan Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Sacubitril Valsartan Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Sacubitril Valsartan Sodium Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Sacubitril Valsartan Sodium Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Pellets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Addii Biotech
  • Arlak Corazon
  • Cipla
  • Farmanova pharma
  • General Pharmaceuticals
  • MSN
  • Novartis
  • Sanof
  • Changzhou Pharmaceutical Factory
  • Chengdu Brilliant Pharmaceutical
  • TC Pharmaceuticals (Jiangsu)
  • Sino Therapeutics
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • Shenzhen Salubris Pharmaceuticals
  • CSPC Ouyi Pharmaceutical
  • Sihuan Pharmaceutical
  • Zhejiang AngLiKang Pharmaceutical
  • Zhejiang Nord Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sacubitril Valsartan Sodium Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sacubitril Valsartan Sodium Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sacubitril Valsartan Sodium Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sacubitril Valsartan Sodium Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sacubitril Valsartan Sodium Drugs Market Dynamics
  1. 2.1 Sacubitril Valsartan Sodium Drugs Industry Trends
  2. 2.2 Sacubitril Valsartan Sodium Drugs Industry Drivers
  3. 2.3 Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges
  4. 2.4 Sacubitril Valsartan Sodium Drugs Industry Restraints
3 Sacubitril Valsartan Sodium Drugs Market by Manufacturers
  1. 3.1 Global Sacubitril Valsartan Sodium Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sacubitril Valsartan Sodium Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sacubitril Valsartan Sodium Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sacubitril Valsartan Sodium Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sacubitril Valsartan Sodium Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sacubitril Valsartan Sodium Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Sacubitril Valsartan Sodium Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sacubitril Valsartan Sodium Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sacubitril Valsartan Sodium Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sacubitril Valsartan Sodium Drugs Tier 1, Tier 2, and Tier 3
4 Sacubitril Valsartan Sodium Drugs Market by Type
  1. 4.1 Sacubitril Valsartan Sodium Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Oral Pellets
  4. 4.2 Global Sacubitril Valsartan Sodium Drugs Sales by Type
  5. 4.2.1 Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sacubitril Valsartan Sodium Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Sacubitril Valsartan Sodium Drugs Revenue by Type
  9. 4.3.1 Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Type (2021-2032)
5 Sacubitril Valsartan Sodium Drugs Market by Application
  1. 5.1 Sacubitril Valsartan Sodium Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Sacubitril Valsartan Sodium Drugs Sales by Application
  6. 5.2.1 Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sacubitril Valsartan Sodium Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sacubitril Valsartan Sodium Drugs Revenue by Application
  10. 5.3.1 Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Application (2021-2032)
6 Global Sacubitril Valsartan Sodium Drugs Sales by Region
  1. 6.1 Global Sacubitril Valsartan Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Sacubitril Valsartan Sodium Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sacubitril Valsartan Sodium Drugs Revenue by Region
  1. 7.1 Global Sacubitril Valsartan Sodium Drugs Revenue by Region
  2. 7.1.1 Global Sacubitril Valsartan Sodium Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sacubitril Valsartan Sodium Drugs Revenue (2021-2032)
  8. 7.2.2 North America Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sacubitril Valsartan Sodium Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Addii Biotech
  2. 8.1.1 Addii Biotech Company Information
  3. 8.1.2 Addii Biotech Business Overview
  4. 8.1.3 Addii Biotech Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio
  6. 8.1.5 Addii Biotech Recent Developments
  7. 8.2 Arlak Corazon
  8. 8.2.1 Arlak Corazon Company Information
  9. 8.2.2 Arlak Corazon Business Overview
  10. 8.2.3 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio
  12. 8.2.5 Arlak Corazon Recent Developments
  13. 8.3 Cipla
  14. 8.3.1 Cipla Company Information
  15. 8.3.2 Cipla Business Overview
  16. 8.3.3 Cipla Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio
  18. 8.3.5 Cipla Recent Developments
  19. 8.4 Farmanova pharma
  20. 8.4.1 Farmanova pharma Company Information
  21. 8.4.2 Farmanova pharma Business Overview
  22. 8.4.3 Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio
  24. 8.4.5 Farmanova pharma Recent Developments
  25. 8.5 General Pharmaceuticals
  26. 8.5.1 General Pharmaceuticals Company Information
  27. 8.5.2 General Pharmaceuticals Business Overview
  28. 8.5.3 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
  30. 8.5.5 General Pharmaceuticals Recent Developments
  31. 8.6 MSN
  32. 8.6.1 MSN Company Information
  33. 8.6.2 MSN Business Overview
  34. 8.6.3 MSN Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MSN Sacubitril Valsartan Sodium Drugs Product Portfolio
  36. 8.6.5 MSN Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Sanof
  44. 8.8.1 Sanof Company Information
  45. 8.8.2 Sanof Business Overview
  46. 8.8.3 Sanof Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio
  48. 8.8.5 Sanof Recent Developments
  49. 8.9 Changzhou Pharmaceutical Factory
  50. 8.9.1 Changzhou Pharmaceutical Factory Company Information
  51. 8.9.2 Changzhou Pharmaceutical Factory Business Overview
  52. 8.9.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio
  54. 8.9.5 Changzhou Pharmaceutical Factory Recent Developments
  55. 8.10 Chengdu Brilliant Pharmaceutical
  56. 8.10.1 Chengdu Brilliant Pharmaceutical Company Information
  57. 8.10.2 Chengdu Brilliant Pharmaceutical Business Overview
  58. 8.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  60. 8.10.5 Chengdu Brilliant Pharmaceutical Recent Developments
  61. 8.11 TC Pharmaceuticals (Jiangsu)
  62. 8.11.1 TC Pharmaceuticals (Jiangsu) Company Information
  63. 8.11.2 TC Pharmaceuticals (Jiangsu) Business Overview
  64. 8.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio
  66. 8.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments
  67. 8.12 Sino Therapeutics
  68. 8.12.1 Sino Therapeutics Company Information
  69. 8.12.2 Sino Therapeutics Business Overview
  70. 8.12.3 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio
  72. 8.12.5 Sino Therapeutics Recent Developments
  73. 8.13 Kelun Pharmaceutical
  74. 8.13.1 Kelun Pharmaceutical Company Information
  75. 8.13.2 Kelun Pharmaceutical Business Overview
  76. 8.13.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  78. 8.13.5 Kelun Pharmaceutical Recent Developments
  79. 8.14 Qilu Pharmaceutical
  80. 8.14.1 Qilu Pharmaceutical Company Information
  81. 8.14.2 Qilu Pharmaceutical Business Overview
  82. 8.14.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  84. 8.14.5 Qilu Pharmaceutical Recent Developments
  85. 8.15 Shenzhen Salubris Pharmaceuticals
  86. 8.15.1 Shenzhen Salubris Pharmaceuticals Company Information
  87. 8.15.2 Shenzhen Salubris Pharmaceuticals Business Overview
  88. 8.15.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
  90. 8.15.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  91. 8.16 CSPC Ouyi Pharmaceutical
  92. 8.16.1 CSPC Ouyi Pharmaceutical Company Information
  93. 8.16.2 CSPC Ouyi Pharmaceutical Business Overview
  94. 8.16.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  96. 8.16.5 CSPC Ouyi Pharmaceutical Recent Developments
  97. 8.17 Sihuan Pharmaceutical
  98. 8.17.1 Sihuan Pharmaceutical Company Information
  99. 8.17.2 Sihuan Pharmaceutical Business Overview
  100. 8.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  102. 8.17.5 Sihuan Pharmaceutical Recent Developments
  103. 8.18 Zhejiang AngLiKang Pharmaceutical
  104. 8.18.1 Zhejiang AngLiKang Pharmaceutical Company Information
  105. 8.18.2 Zhejiang AngLiKang Pharmaceutical Business Overview
  106. 8.18.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  108. 8.18.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
  109. 8.19 Zhejiang Nord Pharmaceutical
  110. 8.19.1 Zhejiang Nord Pharmaceutical Company Information
  111. 8.19.2 Zhejiang Nord Pharmaceutical Business Overview
  112. 8.19.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  114. 8.19.5 Zhejiang Nord Pharmaceutical Recent Developments
  115. 8.20 Chia Tai Tianqing Pharmaceutical
  116. 8.20.1 Chia Tai Tianqing Pharmaceutical Company Information
  117. 8.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
  118. 8.20.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  120. 8.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sacubitril Valsartan Sodium Drugs Value Chain Analysis
  2. 9.1.1 Sacubitril Valsartan Sodium Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sacubitril Valsartan Sodium Drugs Production Mode & Process
  6. 9.2 Sacubitril Valsartan Sodium Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sacubitril Valsartan Sodium Drugs Distributors
  9. 9.2.3 Sacubitril Valsartan Sodium Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst